H1N1 Vaccine Market: Has Pandemic-Era Manufacturing Capacity Become a Permanent Public Health Asset?
H1N1 vaccine's pandemic preparedness legacy — the influenza vaccines specifically targeting the H1N1 influenza A virus strain, including both the vaccines developed and rapidly deployed during the 2009 H1N1 pandemic and the H1N1 component now permanently incorporated into standard seasonal quadrivalent influenza vaccines — represents a segment whose commercial structure has evolved...
0 Yorumlar 0 hisse senetleri 133 Views 0 önizleme